POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,029,081 | +35.4% | 13,037,429 | +0.2% | 0.00% | +50.0% |
| Q2 2023 | $22,908,742 | -71.3% | 13,016,331 | -49.9% | 0.00% | -50.0% |
| Q1 2023 | $79,951,132 | +17.0% | 25,958,160 | +101.3% | 0.00% | -42.9% |
| Q4 2022 | $68,329,757 | +54.3% | 12,892,407 | +2.7% | 0.01% | +40.0% |
| Q3 2022 | $44,298,000 | +82.6% | 12,549,052 | +33.4% | 0.01% | +150.0% |
| Q2 2022 | $24,266,000 | -42.3% | 9,405,708 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $42,033,000 | -34.2% | 9,382,154 | +0.1% | 0.00% | -40.0% |
| Q4 2021 | $63,850,000 | -6.3% | 9,375,941 | +0.3% | 0.01% | 0.0% |
| Q3 2021 | $68,167,000 | -27.0% | 9,350,789 | +0.3% | 0.01% | -28.6% |
| Q2 2021 | $93,418,000 | +5.0% | 9,323,206 | +0.1% | 0.01% | -12.5% |
| Q1 2021 | $88,970,000 | -12.0% | 9,316,225 | +0.5% | 0.01% | -11.1% |
| Q4 2020 | $101,065,000 | +31.4% | 9,273,001 | +0.0% | 0.01% | +12.5% |
| Q3 2020 | $76,914,000 | – | 9,272,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |